Home
Resources
Diseases
COVID-19
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hexavalent vaccines
HPV vaccines
Malaria vaccines
PCV vaccines
RSV vaccines
Training
Vaccine Portfolio Optimization and Prioritization (VPOP)
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (40)
NITAG documentation (1641)
Reports (63)
SAGE documentation (226)
Scientific publications (122)
Systematic reviews (SYSVAC) (3100)
Regions
Africa (297)
Americas (794)
Eastern Mediterranean (58)
Europe (744)
Global (1)
South-East Asia (82)
Western Pacific (216)
Diseases
Chikungunya (13)
Cholera (35)
COVID-19 (1589)
Cytomegalovirus (1)
Dengue (43)
Diphtheria (90)
Ebola (19)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (71)
Hepatitis A (69)
Hepatitis B (171)
Hepatitis C (5)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (77)
HIV / AIDS (10)
Human papillomavirus (HPV) (537)
Influenza (629)
Japanese encephalitis (34)
Lyme disease, Borreliosis (2)
Malaria (33)
Measles (144)
Meningococcal disease (155)
Moraxella catarrhalis (1)
Mpox (58)
Mumps (50)
Pertussis (120)
Pneumococcal disease (305)
Poliomyelitis (94)
Q fever (1)
Rabies (33)
Rotavirus (121)
RSV (Respiratory syncytial virus) (69)
Rubella (69)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (71)
Tick-borne encephalitis (14)
Tuberculosis (83)
Typhoid (32)
Varicella (77)
Yellow fever (44)
Zika (1)
Show more
5192 results found
2024
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against RSV (adults) – revision 2024
2024
∙
Melanie Marti, Hanna Nohynek, Philippe Duclos, Katherine O'Brien, Joachim Hombach
The Strategic Advisory Group of Experts (SAGE) on Immunization—Past, Present and Future
2024
∙
Folkhälsomyndigheten
Evaluation of an introduction of vaccination against varicella in the Swedish national vaccination program for children – Summary of evidence
2024
∙
Folkhälsomyndigheten
Swedish recommendations on vaccination against human papillomavirus (HPV)
2024
∙
Fabienne Krauer, Felix Guenther, Marina Treskova-Schwarzbach, Viktoria Schoenfeld, Mihaly Koltai, Mark Jit, David Hodgson, Udo Schneider, Ole Wichmann, Thomas Harder, Frank G. Sandmann, Flasche, S.
Effectiveness and efficiency of immunisation strategies to prevent RSV among infants and older adults in Germany: a modelling study
2024
SoPs of the Chad NITAG
2024
∙
Haute Autorité de Santé
Vaccination strategy against RSV infections in adults aged 60 and over: role of the mRESVIA vaccine (Moderna)
2024
Updated recommendations for vaccination against mpox in Spain
2024
∙
NIAC
Updated recommendations for pneumococcal conjugate vaccination in childhood in Ireland
2024
∙
ATAGI
ATAGI interim statement on the use of vaccines for prevention of mpox in 2024
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register
